Realtromins

Realtromins is a private U.S. medical device company developing real-time predictive analytics tools for critically ill and hospitalized patients. Its products are described as continuously updated medical devices that assess deterioration or mortality risk across settings including pediatric intensive care units, neonatal ICUs, and non-ICU hospitalized children. The company appears focused on clinical decision support and early warning technologies rather than therapeutics, using advanced analytics to help clinicians identify high-risk patients earlier and guide intervention. Publicly available information indicates the company was founded by Keith Kocis and has been associated with Chapel Hill, North Carolina. Realtromins is healthcare-related, but it is not a biotech or pharmaceutical drug developer.